Dunad Therapeutics Ltd.
12544797
Some Concerns
- Going concern doubt noted in accounts (-10)
- 1 outstanding charge (-2)
Details
Compliance
Last accounts
31/12/2024
group
Next accounts due
30/09/2026
Confirmation statement
Last: 01/04/2026
Due 15/04/2027
Industry
Officers
director · Since 22/04/2020
FUND MANAGER
IRISH · SCOTLAND · Age 51
Also on 3 other boards
director · Since 14/04/2023
DIRECTOR
AMERICAN · UNITED STATES · Age 67
Also on 1 other board
director · Since 14/08/2024
INVESTOR DIRECTOR
BRITISH · UNITED KINGDOM · Age 33
Also on 2 other boards
Persons with Significant Control
Former PSCs
Ms Vanessa Lea Mcminn
Ceased 20/04/2020
Dziyana Kraskouskaya
Ceased 14/08/2024
Epidarex Capital Iii Uk, Lp
Ceased 14/08/2024
Charges1 outstanding
HSBC INNOVATION BANKING
SILICON VALLEY BANK
CompanyRankvs 557+ SIC 72110 peers51
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
relatively short cash runway and the uncertain status of additional fundraising acknowledge a material uncertainty exists in relation to the ability of the group and parent company to continue as a going concern. The Company has identified a number of strategies to reduce costs and continues to explore non-dilutive funding opportunities, such as grants. The current cash balance and the £6m conve
Key FinancialsYear ending 31/12/2024
Net Worth
£9k
Balance sheet strength
Cash
£10.2M
Cash in the bank
Net Current Assets
£8.7M
Working capital
Current Assets
£9.6M
Current Liabilities
£903k
Fixed Assets
£322k
Debtors
£1.6M
Profit After Tax
-£12.0M
People Costs
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 10.59 | +£6k |
| 2023 | 3.57 | +£11 |
| 2022 | — | +£0 |
| 2022 | 3.19 | — |
Derived from filed accounts. Not audited figures.